Table 1

Clinical and audiological characteristics of 54 infants with cCMV infection and failed newborn hearing screening

CharacteristicscCMV-infected infants (n=54)
Infant sex, male, n (%)25 (46)
Gestational age at birth, weeks, mean (SD)39.3 (1.7)
Age at cCMV diagnosis, days, mean (SD)50 (24.3)
Birth weight mean SD (95% CI)−0.48 (–0.72 to –0.23)
 <–23 (6)
 −2 to +251 (94)
 >+20
Head circumference mean SD (95% CI)*−0.70 (–1.04 to –0.35)
 <–26 (12)
 −2 to +245 (88)
 >+20
Audiological outcome, n54
Unilateral conductive hearing loss, n (%)3 (6)
Bilateral conductive hearing loss, n (%)3 (6)
SNHL, n (%)48 (89)
 Unilateral SNHL, n (%)24 (50)
 Bilateral SNHL, n (%)24 (50)
ABR results for SNHLUnilateral†Bilateral‡
24 ears (%)48 ears (%)
Mild hearing loss (21–40 dB)05 (10)
Moderate hearing loss (41–70 dB)4 (17)9 (19)
Severe hearing loss (71–90 dB)4 (17)11 (23)
Profound hearing loss (>90 dB)16 (66)23 (48)
  • *Data available for 51 infants in the first 6 months of life.

  • †Six ears had mixed hearing loss (conductive combined with SNHL). The hearing threshold and type of loss are registered as observed by the audiologist.

  • ‡Fifteen ears with mixed hearing loss (conductive combined with SNHL). The hearing threshold is registered as observed by the audiologist.

  • ABR, auditory brainstem response; cCMV, congenital cytomegalovirus; CI, confidence interval; dB, decibel; SD, standard deviation; SNHL, sensorineural hearing loss.